Subsequently, the same group, by structure–activity relationship (SAR) tools, demonstrated that niclosamide, a widely used uncoupled oxidative phosphorylation compound, targets CREB and, preventing its activation, inhibits CREB-driven gene expression and results in cell cycle arrest and apoptosis in AML cells (54, 55). Here, CREB1 is linked to acute myeloid leukemia.